$ONC
BeiGene, Ltd. Stock $onc

$onc Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-K Financial Statement

#000165130819000018 Filed on February 28, 2019

Income Statement

Concept	2019 Q1	2018 Q4	2018 Q3
Revenue	$77.83M	$58.67M	$54.20M
YoY Change	139.16%	222.82%	-75.39%
Cost Of Revenue	$15.26M		$8.706M
YoY Change	235.41%		347.84%
Gross Profit	$62.57M		$45.50M
YoY Change	123.52%		-79.16%
Gross Profit Margin	80.39%		83.94%
Selling, General & Admin	$57.65M		$48.82M
YoY Change	99.36%		212.13%
% of Gross Profit	92.13%		107.31%
Research & Development	$178.4M		$147.6M
YoY Change	62.58%		68.37%
% of Gross Profit	285.03%		324.4%
Depreciation & Amortization	$3.416M		$2.207M
YoY Change	52.23%		78.42%
% of Gross Profit	5.46%		4.85%
Operating Expenses	$236.0M		$196.4M
YoY Change	70.25%		90.13%
Operating Profit	-$173.8M	-$280.8M	-$151.1M
YoY Change	56.81%	170.53%	-231.5%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$1.728M		$1.585M
YoY Change	137.04%		43.7%
Pretax Income	-$167.6M		-$145.0M
YoY Change	54.38%		-226.91%
Income Tax	$519.0K		-$472.0K
% Of Pretax Income
Net Earnings	-$167.6M	-$268.3M	-$144.0M
YoY Change	60.27%	170.08%	-222.7%
Net Earnings / Revenue	-215.38%	-457.23%	-265.73%
Basic Earnings Per Share		-$0.35	-$0.19
Diluted Earnings Per Share			-$0.19
COMMON SHARES
Basic Shares Outstanding	776.1M shares	772.4M shares	739.8M shares
Diluted Shares Outstanding			739.8M shares

Balance Sheet

Concept	2019 Q1	2018 Q4	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.781B
YoY Change
Cash & Equivalents	$764.5M	$712.9M	$643.5M
Short-Term Investments		$1.069B
Other Short-Term Assets
YoY Change
Inventory	$13.14M	$16.24M	$19.70M
Prepaid Expenses
Receivables	$58.98M	$41.06M	$37.37M
Other Receivables
Total Short-Term Assets	$1.797B	$1.944B	$2.180B
YoY Change		112.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$197.8M	$157.1M	$111.3M
YoY Change		151.02%
Goodwill	$109.0K	$109.0K	$109.0K
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$58.61M	$53.78M	$28.91M
YoY Change	309.05%	25.31%
Total Long-Term Assets	$375.5M	$305.8M	$228.4M
YoY Change		129.99%
TOTAL ASSETS
Total Short-Term Assets	$1.797B	$1.944B	$2.180B
Total Long-Term Assets	$375.5M	$305.8M	$228.4M
Total Assets	$2.172B	$2.250B	$2.409B
YoY Change		114.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$105.3M	$113.3M	$85.55M
YoY Change		62.35%
Accrued Expenses	$99.53M	$100.4M
YoY Change
Deferred Revenue	$17.50M	$18.14M	$16.71M
YoY Change		48.29%
Short-Term Debt
YoY Change
Long-Term Debt Due	$8.940M	$8.727M	$8.736M
YoY Change		-5.37%
Total Short-Term Liabilities	$238.8M	$246.5M	$188.4M
YoY Change		64.31%
LONG-TERM LIABILITIES
Long-Term Debt	$77.48M	$40.79M	$40.82M
YoY Change		342.26%
Other Long-Term Liabilities	$47.92M	$48.77M	$34.88M
YoY Change	118.13%	52.61%
Total Long-Term Liabilities	$310.7M	$249.6M	$236.8M
YoY Change	1314.47%	17.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$238.8M	$246.5M	$188.4M
Total Long-Term Liabilities	$310.7M	$249.6M	$236.8M
Total Liabilities	$549.6M	$496.0M	$425.2M
YoY Change		36.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.175B	-$1.007B	-$739.0M
YoY Change	252.34%	204.74%
Common Stock	$78.00K	$77.00K	$77.00K
YoY Change		30.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.609B	$1.739B	$1.970B
YoY Change
Total Liabilities & Shareholders Equity	$2.172B	$2.250B	$2.409B
YoY Change		114.98%

Cashflow Statement

Concept	2019 Q1	2018 Q4	2018 Q3
OPERATING ACTIVITIES
Net Income	-$167.6M	-$268.3M	-$144.0M
YoY Change	60.27%	170.08%	-222.7%
Depreciation, Depletion And Amortization	$3.416M		$2.207M
YoY Change	52.23%		78.42%
Cash From Operating Activities	-$172.0M
YoY Change	64.57%
INVESTING ACTIVITIES
Capital Expenditures	$21.83M
YoY Change	125.12%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$172.4M
YoY Change	-143.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$42.96M
YoY Change	-94.38%
NET CHANGE
Cash From Operating Activities	-$172.0M
Cash From Investing Activities	$172.4M
Cash From Financing Activities	$42.96M
Net Change In Cash	$47.67M
YoY Change	-82.25%
FREE CASH FLOW
Cash From Operating Activities	-$172.0M
Capital Expenditures	$21.83M
Free Cash Flow	-$193.8M
YoY Change	69.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q4	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	2350000	USD
CY2018Q4	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	10433000	USD
CY2017Q4	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	18721000	USD
CY2018Q4	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	34588000	USD
CY2017Q4	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	2391000	USD
CY2018Q4	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	6727000	USD
CY2017Q4	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	3997000	USD
CY2018Q4	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	4749000	USD
CY2016	bgne	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	0	USD
CY2017	bgne	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	0	USD
CY2018	bgne	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	70000000	USD
CY2016	bgne	Adjustmentsto Changesin Operating Assetsand Liabilities AdjustmentstoChangesinOperatingAssetsandLiabilities	0	USD
CY2017	bgne	Adjustmentsto Changesin Operating Assetsand Liabilities AdjustmentstoChangesinOperatingAssetsandLiabilities	0	USD
CY2018	bgne	Adjustmentsto Changesin Operating Assetsand Liabilities AdjustmentstoChangesinOperatingAssetsandLiabilities	2291000	USD
CY2016	bgne	Cash Acquired From Acquisition Net Of Cash Paid CashAcquiredFromAcquisitionNetOfCashPaid	0	USD
CY2017	bgne	Cash Acquired From Acquisition Net Of Cash Paid CashAcquiredFromAcquisitionNetOfCashPaid	19916000	USD
CY2018	bgne	Cash Acquired From Acquisition Net Of Cash Paid CashAcquiredFromAcquisitionNetOfCashPaid	0	USD
CY2016	bgne	Conversion Of Deferred Rental ConversionOfDeferredRental	980000	USD
CY2017	bgne	Conversion Of Deferred Rental ConversionOfDeferredRental	0	USD
CY2018	bgne	Conversion Of Deferred Rental ConversionOfDeferredRental	0	USD
CY2016	bgne	Conversion Of Warrant And Option Liabilities ConversionOfWarrantAndOptionLiabilities	3687000	USD
CY2017	bgne	Conversion Of Warrant And Option Liabilities ConversionOfWarrantAndOptionLiabilities	0	USD
CY2018	bgne	Conversion Of Warrant And Option Liabilities ConversionOfWarrantAndOptionLiabilities	0	USD
CY2018Q4	bgne	Deferred Tax Liabilities Undistributed Foreign Earnings Unaccounted For DeferredTaxLiabilitiesUndistributedForeignEarningsUnaccountedFor	7100000	USD
CY2016	bgne	Discount Provided For Issuance Of Ordinary Shares DiscountProvidedForIssuanceOfOrdinaryShares	0	USD
CY2017	bgne	Discount Provided For Issuance Of Ordinary Shares DiscountProvidedForIssuanceOfOrdinaryShares	23606000	USD
CY2018	bgne	Discount Provided For Issuance Of Ordinary Shares DiscountProvidedForIssuanceOfOrdinaryShares	0	USD
CY2016	bgne	Earnings Per American Depository Share EarningsPerAmericanDepositoryShare	-3.84
CY2017	bgne	Earnings Per American Depository Share EarningsPerAmericanDepositoryShare	-2.23
CY2018	bgne	Earnings Per American Depository Share EarningsPerAmericanDepositoryShare	-12.15
CY2018Q4	bgne	Employee Service Share Based Compensation Nonvested Awards Compensation Not Yet Recognized Stock Options Number EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptionsNumber	56027926	shares
CY2016	bgne	Follow On Offering Costs Accrued In Accounts Payable FollowOnOfferingCostsAccruedInAccountsPayable	269000	USD
CY2017	bgne	Follow On Offering Costs Accrued In Accounts Payable FollowOnOfferingCostsAccruedInAccountsPayable	0	USD
CY2018	bgne	Follow On Offering Costs Accrued In Accounts Payable FollowOnOfferingCostsAccruedInAccountsPayable	0	USD
CY2016	bgne	Gains Losses From Decrease Increase In Fair Value Of Financial Instruments GainsLossesFromDecreaseIncreaseInFairValueOfFinancialInstruments	-1514000	USD
CY2017	bgne	Gains Losses From Decrease Increase In Fair Value Of Financial Instruments GainsLossesFromDecreaseIncreaseInFairValueOfFinancialInstruments	0	USD
CY2018	bgne	Gains Losses From Decrease Increase In Fair Value Of Financial Instruments GainsLossesFromDecreaseIncreaseInFairValueOfFinancialInstruments	0	USD
CY2017Q4	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	31804000	USD
CY2018Q4	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	37851000	USD
CY2016	bgne	Income Tax Reconciliation Intercompany Restructuring Deduction IncomeTaxReconciliationIntercompanyRestructuringDeduction	0	USD
CY2017	bgne	Income Tax Reconciliation Intercompany Restructuring Deduction IncomeTaxReconciliationIntercompanyRestructuringDeduction	29438000	USD
CY2018	bgne	Income Tax Reconciliation Intercompany Restructuring Deduction IncomeTaxReconciliationIntercompanyRestructuringDeduction	0	USD
CY2018	bgne	Income Tax Reconciliation Net Operating Loss Expiration IncomeTaxReconciliationNetOperatingLossExpiration	1637000	USD
CY2016	bgne	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1070000	USD
CY2017	bgne	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	37041000	USD
CY2018	bgne	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-9059000	USD
CY2016	bgne	Interest Expense Operating Activities InterestExpenseOperatingActivities	121000	USD
CY2017	bgne	Interest Expense Operating Activities InterestExpenseOperatingActivities	7035000	USD
CY2018	bgne	Interest Expense Operating Activities InterestExpenseOperatingActivities	7820000	USD
CY2018Q4	bgne	Land Use Right Net Expected Amortization Expense After Year Five LandUseRightNetExpectedAmortizationExpenseAfterYearFive	39153000	USD
CY2018Q4	bgne	Land Use Right Net Expected Amortization Expense Year Five LandUseRightNetExpectedAmortizationExpenseYearFive	1181000	USD
CY2018Q4	bgne	Land Use Right Net Expected Amortization Expense Year Four LandUseRightNetExpectedAmortizationExpenseYearFour	1181000	USD
CY2018Q4	bgne	Land Use Right Net Expected Amortization Expense Year One LandUseRightNetExpectedAmortizationExpenseYearOne	1181000	USD
CY2018Q4	bgne	Land Use Right Net Expected Amortization Expense Year Three LandUseRightNetExpectedAmortizationExpenseYearThree	1181000	USD
CY2018Q4	bgne	Land Use Right Net Expected Amortization Expense Year Two LandUseRightNetExpectedAmortizationExpenseYearTwo	1181000	USD
CY2018	bgne	Land Use Right Term LandUseRightTerm	P50Y
CY2017Q4	bgne	Land Use Rights Accumulated Amortization LandUseRightsAccumulatedAmortization	168000	USD
CY2018Q4	bgne	Land Use Rights Accumulated Amortization LandUseRightsAccumulatedAmortization	643000	USD
CY2016	bgne	Land Use Rights Amortization Expense LandUseRightsAmortizationExpense	0	USD
CY2017	bgne	Land Use Rights Amortization Expense LandUseRightsAmortizationExpense	168000	USD
CY2018	bgne	Land Use Rights Amortization Expense LandUseRightsAmortizationExpense	494000	USD
CY2017Q4	bgne	Land Use Rights Gross LandUseRightsGross	12633000	USD
CY2018Q4	bgne	Land Use Rights Gross LandUseRightsGross	45701000	USD
CY2016Q1	bgne	Options And Warrants Exercised Carrying Value Reclassified From Current Liabilities To Stockholder S Equity OptionsAndWarrantsExercisedCarryingValueReclassifiedFromCurrentLiabilitiesToStockholderSEquity	3687000	USD
CY2016	bgne	Paymentfor Asset Acquisition PaymentforAssetAcquisition	0	USD
CY2017	bgne	Paymentfor Asset Acquisition PaymentforAssetAcquisition	0	USD
CY2018	bgne	Paymentfor Asset Acquisition PaymentforAssetAcquisition	38298000	USD
CY2016	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	0	USD
CY2017	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	0	USD
CY2018	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	70000000	USD
CY2016	bgne	Paymentsfor Land Use Right PaymentsforLandUseRight	0	USD
CY2017	bgne	Paymentsfor Land Use Right PaymentsforLandUseRight	12354000	USD
CY2018	bgne	Paymentsfor Land Use Right PaymentsforLandUseRight	0	USD
CY2016	bgne	Paymentsof Initial Public Offering Costand Stock Issuance Cost PaymentsofInitialPublicOfferingCostandStockIssuanceCost	0	USD
CY2017	bgne	Paymentsof Initial Public Offering Costand Stock Issuance Cost PaymentsofInitialPublicOfferingCostandStockIssuanceCost	0	USD
CY2018	bgne	Paymentsof Initial Public Offering Costand Stock Issuance Cost PaymentsofInitialPublicOfferingCostandStockIssuanceCost	5659000	USD
CY2017Q4	bgne	Prepaid Construction Cost PrepaidConstructionCost	0	USD
CY2018Q4	bgne	Prepaid Construction Cost PrepaidConstructionCost	25193000	USD
CY2017Q4	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	12867000	USD
CY2018Q4	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	11981000	USD
CY2016	bgne	Proceeds From Issuance Of Common Stock Net Of Underwriter Discount ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount	368877000	USD
CY2017	bgne	Proceeds From Issuance Of Common Stock Net Of Underwriter Discount ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount	189191000	USD
CY2018	bgne	Proceeds From Issuance Of Common Stock Net Of Underwriter Discount ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount	758001000	USD
CY2016	bgne	Proceedsfrom Common Stock Issuanceand Initial Public Offering ProceedsfromCommonStockIssuanceandInitialPublicOffering	0	USD
CY2017	bgne	Proceedsfrom Common Stock Issuanceand Initial Public Offering ProceedsfromCommonStockIssuanceandInitialPublicOffering	0	USD
CY2018	bgne	Proceedsfrom Common Stock Issuanceand Initial Public Offering ProceedsfromCommonStockIssuanceandInitialPublicOffering	875368000	USD
CY2017Q4	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	21156000	USD
CY2018Q4	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	58673000	USD
CY2016	bgne	Purchaseof Inprocessanddevelopment Includedin Accounts Payable PurchaseofInprocessanddevelopmentIncludedinAccountsPayable	0	USD
CY2017	bgne	Purchaseof Inprocessanddevelopment Includedin Accounts Payable PurchaseofInprocessanddevelopmentIncludedinAccountsPayable	0	USD
CY2018	bgne	Purchaseof Inprocessanddevelopment Includedin Accounts Payable PurchaseofInprocessanddevelopmentIncludedinAccountsPayable	19000000	USD
CY2017Q4	bgne	Rental Deposits And Other RentalDepositsAndOther	1460000	USD
CY2018Q4	bgne	Rental Deposits And Other RentalDepositsAndOther	1823000	USD
CY2016Q4	bgne	Restricted Net Assets Appropriated To Statutory Reserves RestrictedNetAssetsAppropriatedToStatutoryReserves	0	USD
CY2017Q4	bgne	Restricted Net Assets Appropriated To Statutory Reserves RestrictedNetAssetsAppropriatedToStatutoryReserves	0	USD
CY2018Q4	bgne	Restricted Net Assets Appropriated To Statutory Reserves RestrictedNetAssetsAppropriatedToStatutoryReserves	0	USD
CY2018Q4	bgne	Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage	0.1
CY2018Q4	bgne	Restricted Net Assets Required Statutory Reserve As Percentage Of Registered Capital RestrictedNetAssetsRequiredStatutoryReserveAsPercentageOfRegisteredCapital	0.5
CY2017Q3	bgne	Share Price American Depositary Shares SharePriceAmericanDepositaryShares	59.55
CY2017Q4	bgne	Short Term Investments Accumulated Gross Unrealized Gain Before Tax ShortTermInvestmentsAccumulatedGrossUnrealizedGainBeforeTax	12000	USD
CY2018Q4	bgne	Short Term Investments Accumulated Gross Unrealized Gain Before Tax ShortTermInvestmentsAccumulatedGrossUnrealizedGainBeforeTax	1802000	USD
CY2017Q4	bgne	Short Term Investments Accumulated Gross Unrealized Loss Before Tax ShortTermInvestmentsAccumulatedGrossUnrealizedLossBeforeTax	406000	USD
CY2018Q4	bgne	Short Term Investments Accumulated Gross Unrealized Loss Before Tax ShortTermInvestmentsAccumulatedGrossUnrealizedLossBeforeTax	63000	USD
CY2017Q4	bgne	Short Term Investments Amortized Cost Basis ShortTermInvestmentsAmortizedCostBasis	598308000	USD
CY2018Q4	bgne	Short Term Investments Amortized Cost Basis ShortTermInvestmentsAmortizedCostBasis	1066770000	USD
CY2017Q4	bgne	Tax On Intra Entity Contribution Of Subsidiary Noncurrent TaxOnIntraEntityContributionOfSubsidiaryNoncurrent	28588000	USD
CY2018Q4	bgne	Tax On Intra Entity Contribution Of Subsidiary Noncurrent TaxOnIntraEntityContributionOfSubsidiaryNoncurrent	0	USD
CY2016	bgne	Weighted Average Numberof American Depository Shares Outstanding WeightedAverageNumberofAmericanDepositorySharesOutstanding	31047650	shares
CY2017	bgne	Weighted Average Numberof American Depository Shares Outstanding WeightedAverageNumberofAmericanDepositorySharesOutstanding	41783497	shares
CY2018	bgne	Weighted Average Numberof American Depository Shares Outstanding WeightedAverageNumberofAmericanDepositorySharesOutstanding	55442601	shares
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001651308
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	776113184	shares
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q2	dei	Entity Public Float EntityPublicFloat	4600000000	USD
CY2018	dei	Entity Registrant Name EntityRegistrantName	BeiGene, Ltd.
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	49598000	USD
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	100414000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	69779000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	113283000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29428000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41056000	USD
CY2017Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5088000	USD
CY2018Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	8030000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13627000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19722000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-480000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1526000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-217000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1000747000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2744814000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	23606000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10625000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42863000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	87127000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2016	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2017	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-8034000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	250000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	894000	USD
CY2017Q4	us-gaap	Assets Assets	1046479000	USD
CY2018Q4	us-gaap	Assets Assets	2249684000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	913497000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	1943842000	USD
CY2017Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	132982000	USD
CY2018Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	305842000	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2153000	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2215000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	22105000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87514000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	239602000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	712937000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17869000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87514000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	239602000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	740713000	USD
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	69645000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	152088000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	501111000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	592072330	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	776263184	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	592072330	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	776263184	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	59000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	77000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-118354000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-92639000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-672026000	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-6052000	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-19627000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7675000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	29542000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-768000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5937000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-22309000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-105000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-352000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-118354000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-92744000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-672378000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	12233000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	18140000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	24808000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9842000	USD
CY2016	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	176084000	USD
CY2017	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2018	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2016	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4974000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	28705000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	118130000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	336844000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	903989000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-2291000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	822000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	5695000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-377000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	822000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	8172000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6513000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2477000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6890000	USD
CY2016	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	14693000	USD
CY2017	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2018	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-768000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	14000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	370000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	11139000	USD
CY2016	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-768000	USD
CY2017	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-5845000	USD
CY2018	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-21949000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	115000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2682000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8089000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	44645000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	261348000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	768000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7675000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	18403000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	782000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8045000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	18403000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	6987000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	29801000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	61266000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	158639000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2449000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	13608000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4639000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8642000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1102000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	7756000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	19193000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7307000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	36600000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	242945000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	14000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	370000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2016	us-gaap	Depreciation Depreciation	1909000	USD
CY2017	us-gaap	Depreciation Depreciation	4340000	USD
CY2018	us-gaap	Depreciation Depreciation	9000000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1909000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4758000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10388000	USD
CY2017Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	146271000	USD
CY2018Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	148888000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.30
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.93
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	104000	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	5299000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-4096000	USD
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.025
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.023
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17051000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	35887000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M24D
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	154623000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	250000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1144000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2750000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1326000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	750000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	750000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	750000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	846000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7500000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8316000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7250000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7172000	USD
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2017	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-85000	USD
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-126000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	109000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	109000	USD
CY2017	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2016	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2017	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2018	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-7352000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-59590000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-130552000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-119163000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-91064000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-689829000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	54000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2235000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15796000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1627000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	30356000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	34009000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	2642000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	1538000	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	27830000	USD
CY2017	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	23275000	USD
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	134673000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-29791000	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-22766000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-172457000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	593000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1608000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	4471000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1989000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-5371000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	205000	USD
CY2017	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	5431000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	12659000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	25000	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	29286000	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12361000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2707000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	55298000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	23470000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	29428000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11628000	USD
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	804000	USD
CY2017	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	7426000	USD
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-3355000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10930000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5312000	USD
CY2016	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	13946000	USD
CY2017	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	24978000	USD
CY2018	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	50543000	USD
CY2016	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-112000	USD
CY2017	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	29701000	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	40228000	USD
CY2016	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	459000	USD
CY2017	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	31395000	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	16962000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2070000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	28880000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	46302000	USD
CY2016	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	0	USD
CY2017	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	0	USD
CY2018	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-7695000	USD
CY2017	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	614000	USD
CY2017	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	7649000	USD
CY2016	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	383000	USD
CY2017	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4108000	USD
CY2018	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	13947000	USD
CY2016	us-gaap	Interest Paid Net InterestPaidNet	826000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	1260000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	2209000	USD
CY2017Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	1557000	USD
CY2018Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	3096000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	10930000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	16242000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1974000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3810000	USD
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	8930000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	362248000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	496037000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1046479000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2249684000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	149988000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	246452000	USD
CY2017Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	212260000	USD
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	249585000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	9222000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8727000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9222000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	40785000	USD
CY2016	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-1415000	USD
CY2017	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	44000	USD
CY2018	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	1948000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	14422000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	14445000	USD
CY2018Q1	us-gaap	Minority Interest MinorityInterest	14797000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	380902000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-51542000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-58022000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	114905000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-103798000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-98457000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-110809000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-163050000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-151102000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-280808000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-705769000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	490356000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1690537000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-221848000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-356319000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-637613000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-89513000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12752000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-547717000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-119217000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-50623000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-60545000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	117386000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-99323000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-93105000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-104596000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-156887000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-144031000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-268255000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-673769000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-194000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-264000	USD
CY2017	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	14527000	USD
CY2018	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-117060000	USD
CY2017Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12465000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	45058000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	33809000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	10752000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	3923000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	7805000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	9972000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1357000	USD
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	209979000	USD
CY2018Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	300769000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42915000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53668000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14327000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-245000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	851000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-478000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	863000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	555000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1655000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1108000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-296000	USD
CY2018	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2133000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	31959000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	38931000	USD
CY2018Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	21969000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-972000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11501000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1993000	USD
CY2017Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	3016000	USD
CY2018Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	5585000	USD
CY2017Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	155000	USD
CY2018Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	1080000	USD
CY2016	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2218000	USD
CY2017	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	674000	USD
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	414000	USD
CY2016	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	382093000	USD
CY2017	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	741296000	USD
CY2018	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	2635686000	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	553000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23502000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	46374000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	70283000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35623000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	81942000	USD
CY2017Q4	us-gaap	Prepaid Taxes PrepaidTaxes	9894000	USD
CY2018Q4	us-gaap	Prepaid Taxes PrepaidTaxes	14588000	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	149928000	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2016	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	12048000	USD
CY2017	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2016	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
CY2017	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	2470000	USD
CY2018	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	42315000	USD
CY2016	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2017	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	14527000	USD
CY2018	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2016	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2017	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	132757000	USD
CY2018	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2016	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	183743000	USD
CY2017	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	423789000	USD
CY2018	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2177207000	USD
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4000	USD
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2016	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2017	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2470000	USD
CY2018	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	80000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4627000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	29662000	USD
CY2016	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2115000	USD
CY2017	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2018	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-119217000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	-50623000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	-60680000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	117284000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	-99280000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	-93299000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-105116000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	-157715000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	-144492000	USD
CY2018Q4	us-gaap	Profit Loss ProfitLoss	-266710000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-674033000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	50070000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	77296000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62568000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	157061000	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2017	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2018	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8736000	USD
CY2018	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	98033000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	269018000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	352907000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	679005000	USD
CY2018Q1	us-gaap	Restricted Cash RestrictedCash	27776000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	14544000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	13232000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-330517000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1007215000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-333446000	USD
CY2016	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1070000	USD
CY2017Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2017Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	220213000	USD
CY2017Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18174000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	238387000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32544000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	52804000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54202000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	58670000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	198220000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20097000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	62602000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	195385000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	10625000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	42863000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	87127000	USD
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2821000	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	20440000	USD
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	55642000	USD
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	597914000	USD
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	1068509000	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	149928000	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	10704000	USD
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	42863000	USD
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	87127000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3519000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4627000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	29662000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	669809000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1739202000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-101765000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	684231000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1753647000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	681940000	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	9156000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	5888000	USD
CY2017Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	0	USD
CY2018Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	8612000	USD
CY2018Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	16307000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	110000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	918000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2295000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	91000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	44000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	110000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	665000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1410000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	234000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	11000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1532000	USD
CY2017Q4	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	0	USD
CY2018Q4	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	14671000	USD
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	403619446	shares
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	543185460	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	720753819	shares
CY2018	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Risks</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of credit risk</font></div><div style="line-height:120%;padding-bottom:16px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that are potentially subject to credit risk consist of cash and cash equivalents and short-term investments. The carrying amounts of cash and cash equivalents and short-term investments represent the maximum amount of loss due to credit risk. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$712,937</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$239,602</font><font style="font-family:inherit;font-size:10pt;"> were deposited with various major reputable financial institutions located in the PRC and international financial institutions outside of the PRC. The deposits placed with financial institutions are not protected by statutory or commercial insurance. In the event of bankruptcy of one of these financial institutions, the Company may be unlikely to claim its deposits back in full. Management believes that these financial institutions are of high credit quality and continually monitors the credit worthiness of these financial institutions. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had short-term investments amounting to </font><font style="font-family:inherit;font-size:10pt;">$1,068,509</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$597,914</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:16px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company’s short-term investments were comprised of U.S. treasury securities. The Company believes that U.S. treasury securities are of high credit quality and continually monitor the credit worthiness of these institutions.</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Customer concentration risk</font></div><div style="line-height:120%;padding-bottom:16px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and 2017, substantially all of the Company's revenue was from Celgene and our product distributor in China. For the year ended </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, substantially all of the Company’s revenue was generated solely from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> customer, Merck KGaA, Darmstadt Germany.  </font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business, customer, political, social and economic risks</font></div><div style="line-height:120%;padding-bottom:16px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company participates in a dynamic biopharmaceutical industry and believes that changes in any of the following areas could have a material adverse effect on the Company’s future financial position, results of operations or cash flows: changes in the overall demand for services and products; competitive pressures due to new entrants; advances and new trends in new drugs and industry standards; changes in clinical research organizations, contract manufacturers and other key vendors; changes in certain strategic relationships or customer relationships; regulatory considerations; intellectual property considerations; and risks associated with the Company’s ability to attract and retain employees necessary to support its growth. The Company’s operations could be also adversely affected by significant political, economic and social uncertainties in the PRC.</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Currency convertibility risk</font></div><div style="line-height:120%;padding-bottom:16px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A significant portion of the Company’s expenses, assets and liabilities are denominated in RMB. On January 1, 1994, the PRC government abolished the dual rate system and introduced a single rate of exchange as quoted daily by the People’s Bank of China (the “PBOC”). However, the unification of the exchange rates does not imply that the RMB may be readily convertible into U.S. dollar or other foreign currencies. All foreign exchange transactions continue to take place either through the PBOC or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the PBOC. Approvals of foreign currency payments by the PBOC or other institutions require submitting a payment application form together with suppliers’ invoices, shipping documents and signed contracts.</font></div><div style="line-height:120%;padding-bottom:16px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, the value of the RMB is subject to changes in central government policies and international economic and political developments affecting supply and demand in the PRC foreign exchange trading system market.</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign currency exchange rate risk</font></div><div style="line-height:120%;padding-bottom:16px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From July 21, 2005, the RMB is permitted to fluctuate within a narrow and managed band against a basket of certain foreign currencies. For RMB against U.S. dollar, there was depreciation of approximately </font><font style="font-family:inherit;font-size:10pt;">5.7%</font><font style="font-family:inherit;font-size:10pt;">, appreciation of approximately </font><font style="font-family:inherit;font-size:10pt;">6.5%</font><font style="font-family:inherit;font-size:10pt;"> and depreciation of approximately </font><font style="font-family:inherit;font-size:10pt;">6.3%</font><font style="font-family:inherit;font-size:10pt;">, in the years ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">. It is difficult to predict how market forces or PRC or U.S. government policy may impact the exchange rate between the RMB and the U.S. dollar in the future.</font></div><div style="line-height:120%;padding-bottom:16px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To the extent that the Company needs to convert U.S. dollar into RMB for capital expenditures and working capital and other business purposes, appreciation of RMB against U.S. dollar would have an adverse effect on the RMB amount the Company would receive from the conversion. Conversely, if the Company decides to convert RMB into U.S. dollar for the purpose of making payments for dividends on ordinary shares, strategic acquisitions or investments or other business purposes, appreciation of U.S. dollar against RMB would have a negative effect on the U.S. dollar amount available to the Company. In addition, a significant depreciation of the RMB against the U.S. dollar may significantly reduce the U.S. dollar equivalent of the Company’s earnings or losses.</font></div></div>
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:16px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, estimating the useful lives of long-lived assets, estimating variable consideration in product sales and collaboration revenue arrangements, identifying separate accounting units and the standalone selling price of each performance obligation in the Company’s revenue arrangements, estimating the fair value of net assets acquired in business combinations, assessing the impairment of long-lived assets, share-based compensation expenses, realizability of deferred tax assets, estimating uncertain tax positions and the fair value of financial instruments. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001651308-19-000018-index-headers.html	Edgar Link	pending
0001651308-19-000018-index.html	Edgar Link	pending
0001651308-19-000018.txt	Edgar Link	pending
0001651308-19-000018-xbrl.zip	Edgar Link	pending
bgne-20181231.xml	Edgar Link	completed
bgne-20181231.xsd	Edgar Link	pending
bgne-20181231_10k.htm	Edgar Link	pending
bgne-20181231_cal.xml	Edgar Link	unprocessable
bgne-20181231_def.xml	Edgar Link	unprocessable
bgne-20181231_lab.xml	Edgar Link	unprocessable
bgne-20181231_pre.xml	Edgar Link	unprocessable
capturea01.jpg	Edgar Link	pending
exhibit211-subsidiaries.htm	Edgar Link	pending
exhibit231-auditorsconsent.htm	Edgar Link	pending
exhibit311-302certceo.htm	Edgar Link	pending
exhibit312-302certcfo.htm	Edgar Link	pending
exhibit321-906cert.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
productsv2.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONC
BeiGene, Ltd. Stock $onc

2019 Q1 Form 10-K Financial Statement

#000165130819000018 Filed on February 28, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC BeiGene, Ltd. Stock $onc

2019 Q1 Form 10-K Financial Statement

#000165130819000018 Filed on February 28, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC
BeiGene, Ltd. Stock $onc